Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 85,866Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6SANOFI-AVENTIS CANADA INC

02 1BIOCON SDN.BHD

03 2ELI LILLY CANADA INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Schedule D

Registration Country : Canada

INSULIN GLARGINE

Brand Name : LANTUS

Dosage Form : SOLUTION

Dosage Strength : 100UNIT/ML

Packaging : 3ML

Approval Date :

Application Number : 2251930

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

02

arrow
Antibody Engineering
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Schedule D

Registration Country : Canada

INSULIN GLARGINE

Brand Name : LANTUS

Dosage Form : SOLUTION

Dosage Strength : 100UNIT/ML

Packaging : 10ML

Approval Date :

Application Number : 2245689

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

03

arrow
Antibody Engineering
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Schedule D

Registration Country : Canada

INSULIN GLARGINE

Brand Name : LANTUS

Dosage Form : SOLUTION

Dosage Strength : 100UNIT/ML

Packaging : 5X3ML

Approval Date :

Application Number : 2294338

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

04

arrow
Antibody Engineering
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Schedule D

Registration Country : Canada

INSULIN GLARGINE

Brand Name : TOUJEO DOUBLESTAR

Dosage Form : SOLUTION

Dosage Strength : 300UNIT/ML

Packaging :

Approval Date :

Application Number : 2493373

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

05

arrow
Antibody Engineering
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Prescription

Registration Country : Canada

INSULIN GLARGINE

Brand Name : SOLIQUA

Dosage Form : SOLUTION

Dosage Strength : 100UNIT/ML

Packaging :

Approval Date :

Application Number : 2478293

Regulatory Info : Prescription

Registration Country : Canada

Sanofi Company Banner

06

arrow
Antibody Engineering
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Schedule D

Registration Country : Canada

INSULIN GLARGINE

Brand Name : TOUJEO SOLOSTAR

Dosage Form : SOLUTION

Dosage Strength : 300UNIT/ML

Packaging : 3X1.5ML/ 5X1.5ML

Approval Date :

Application Number : 2441829

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

07

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

INSULIN GLARGINE

Brand Name : SEMGLEE

Dosage Form : SOLUTION

Dosage Strength : 100UNIT/ML

Packaging :

Approval Date :

Application Number : 2526441

Regulatory Info : Schedule D

Registration Country : Canada

blank

08

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

INSULIN GLARGINE

Brand Name : BASAGLAR

Dosage Form : SOLUTION

Dosage Strength : 100UNIT/ML

Packaging : 3ML

Approval Date :

Application Number : 2461528

Regulatory Info : Schedule D

Registration Country : Canada

blank

09

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

INSULIN GLARGINE

Brand Name : BASAGLAR

Dosage Form : SOLUTION

Dosage Strength : 100UNIT/ML

Packaging :

Approval Date :

Application Number : 2444844

Regulatory Info : Schedule D

Registration Country : Canada

blank